VEGFA and metastatic neoplasm: Given the excessive expression of vascular endothelial growth factor (VEGF) in UM patients with metastatic diseases, anti-VEGF strategies are being tested in clinical trials and pre-clinical animal models.<h4>Conclusions</h4>This review summarizes an overview of current therapies and the development of therapeutic strategies in clinical trials and pre-clinical animal models.